IIM
EWTX icon

INTECH Investment Management’s Edgewise Therapeutics EWTX Stock Holding History

INTECH Investment Management’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$674K Sell
16,578
-1,902
-10% -$65.6K 0.01% 1207
2026
Q1 		$582K Sell
18,480
-11,909
-39% -$343K 0.01% 1266
2025
Q4 		$754K Buy
30,389
+1,210
+4% +$24.3K 0.01% 1287
2025
Q3 		$473K Sell
29,179
-14,886
-34% -$211K ﹤0.01% 1607
2025
Q2 		$578K Sell
44,065
-2,143
-5% -$30.9K 0.01% 1521
2025
Q1 		$1.02M Buy
46,208
+11,364
+33% +$298K 0.01% 1188
2024
Q4 		$930K Buy
34,844
+14,944
+75% +$476K 0.01% 1202
2024
Q3 		$531K Buy
+19,900
New +$396K 0.01% 1193

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

INTECH Investment Management's EWTX Position: Q2 2026 in Review

INTECH Investment Management reduced its Edgewise Therapeutics (EWTX) stake by 10% in Q2 2026, selling an estimated $65.6K and leaving 16,578 shares worth $674K. The position accounts for 0.01% of the portfolio, ranked #1207.

INTECH Investment Management first reported a position in EWTX in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.02M in Q1 2025. 223 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • INTECH Investment Management held 16,578 shares of Edgewise Therapeutics worth $674K as of Q2 2026.
  • INTECH Investment Management sold 1,902 Edgewise Therapeutics shares in Q2 2026, an estimated $65.6K.
  • Edgewise Therapeutics made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1207 holding.
  • INTECH Investment Management first reported a position in Edgewise Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Edgewise Therapeutics position peaked at $1.02M in Q1 2025.
  • 223 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.